Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1061

1.

Treatment complexities among patients with tuberculosis in a high HIV prevalence cohort in the United States.

Bizune D, Kempker R, Kagei M, Yamin A, Mohamed O, Holland DP, Oladele A, Wang YF, Rebolledo PA, Blumberg H, Ray SM, Schechter MC.

AIDS Res Hum Retroviruses. 2018 Aug 14. doi: 10.1089/AID.2018.0126. [Epub ahead of print]

PMID:
30105915
2.

Relationship of Initial Pancreatic Enzyme Replacement Therapy Dose with Weight Gain in Infants with Cystic Fibrosis.

Schechter M, Michel S, Liu S, Seo BW, Kapoor M, Khurmi R, Haupt M.

J Pediatr Gastroenterol Nutr. 2018 Jul 26. doi: 10.1097/MPG.0000000000002108. [Epub ahead of print]

PMID:
30052568
3.

Internal Medicine Residents' Knowledge and Practice of Pulmonary Tuberculosis Diagnosis.

Chida N, Brown C, Mathad J, Carpenter K, Nelson G, Schechter MC, Giles N, Rebolledo PA, Ray S, Fabre V, Cantillo DS, Longworth S, Amorosa V, Petrauskis C, Boulanger C, Cain N, Gupta A, McKenzie-White J, Bollinger R, Melia MT.

Open Forum Infect Dis. 2018 Jun 27;5(7):ofy152. doi: 10.1093/ofid/ofy152. eCollection 2018 Jul.

4.

Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet Commission.

Bekker LG, Alleyne G, Baral S, Cepeda J, Daskalakis D, Dowdy D, Dybul M, Eholie S, Esom K, Garnett G, Grimsrud A, Hakim J, Havlir D, Isbell MT, Johnson L, Kamarulzaman A, Kasaie P, Kazatchkine M, Kilonzo N, Klag M, Klein M, Lewin SR, Luo C, Makofane K, Martin NK, Mayer K, Millett G, Ntusi N, Pace L, Pike C, Piot P, Pozniak A, Quinn TC, Rockstroh J, Ratevosian J, Ryan O, Sippel S, Spire B, Soucat A, Starrs A, Strathdee SA, Thomson N, Vella S, Schechter M, Vickerman P, Weir B, Beyrer C.

Lancet. 2018 Jul 28;392(10144):312-358. doi: 10.1016/S0140-6736(18)31070-5. Epub 2018 Jul 20. Review. No abstract available.

PMID:
30032975
5.

Impact of a program ensuring consistent response to acute drops in lung function in children with cystic fibrosis.

Schechter MS, Schmidt HJ, Williams R, Norton R, Taylor D, Molzhon A.

J Cyst Fibros. 2018 Jul 13. pii: S1569-1993(18)30628-3. doi: 10.1016/j.jcf.2018.06.003. [Epub ahead of print]

PMID:
30017327
6.

Reevaluating approaches to cystic fibrosis pulmonary exacerbations.

Schechter MS.

Pediatr Pulmonol. 2018 Jul 6. doi: 10.1002/ppul.24125. [Epub ahead of print] Review.

PMID:
29979495
7.

Developing an Assessment Framework for Essential Internal Medicine Subspecialty Topics.

Chida N, Brown C, Mathad J, Carpenter K, Nelson G, Schechter MC, Rebolledo PA, Fabre V, Cantillo DS, Longworth S, Amorosa V, Petrauskis C, Boulanger C, Cain N, Gupta A, McKenzie-White J, Bollinger R, Melia M.

J Grad Med Educ. 2018 Jun;10(3):331-335. doi: 10.4300/JGME-D-17-00377.1.

PMID:
29946392
8.

The association between nicotine dependence and physical health among people receiving injectable diacetylmorphine or hydromorphone for the treatment of chronic opioid use disorder.

Palis H, Marchand K, Karamouzian M, MacDonald S, Harrison S, Guh D, Lock K, Brissette S, Anis AH, Krausz M, Marsh DC, Schechter MT, Oviedo-Joekes E.

Addict Behav Rep. 2018 Mar 27;7:82-89. doi: 10.1016/j.abrep.2018.03.005. eCollection 2018 Jun.

9.

Exfoliated molybdenum di-sulfide (MoS2) electrode for hydrogen production in microbial electrolysis cell.

Rozenfeld S, Teller H, Schechter M, Farber R, Krichevski O, Schechter A, Cahan R.

Bioelectrochemistry. 2018 Oct;123:201-210. doi: 10.1016/j.bioelechem.2018.05.007. Epub 2018 May 19.

PMID:
29807268
10.

Reply to Kojima and Klausner.

Nachega JB, Sam-Agudu NA, Mofenson LM, Schechter M, Mellors JW.

Clin Infect Dis. 2018 Apr 27. doi: 10.1093/cid/ciy345. [Epub ahead of print] No abstract available.

PMID:
29718304
11.

Challenges Across the HIV Care Continuum for Patients With HIV/1 TB Co-infection in Atlanta, GA.

Schechter MC, Bizune D, Kagei M, Holland DP, Del Rio C, Yamin A, Mohamed O, Oladele A, Wang YF, Rebolledo PA, Ray SM, Kempker RR.

Open Forum Infect Dis. 2018 Mar 21;5(4):ofy063. doi: 10.1093/ofid/ofy063. eCollection 2018 Apr. Erratum in: Open Forum Infect Dis. 2018 Apr 30;5(4):ofy079.

12.

Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial.

Bansback N, Guh D, Oviedo-Joekes E, Brissette S, Harrison S, Janmohamed A, Krausz M, MacDonald S, Marsh DC, Schechter MT, Anis AH.

Addiction. 2018 Jul;113(7):1264-1273. doi: 10.1111/add.14171. Epub 2018 Mar 28.

PMID:
29589873
13.

Cango Lyec (Healing the Elephant): Gender Differences in HIV Infection in Post-conflict Northern Uganda.

Spittal PM, Malamba SS, Ogwang MD, Musisi S, Ekwaru JP, Sewankambo NK, Pearce ME, Jongbloed K, Patel SH, Katamba A, Blair AH, Muyinda H, Schechter MT.

J Acquir Immune Defic Syndr. 2018 Jul 1;78(3):257-268. doi: 10.1097/QAI.0000000000001671.

15.

Metabolic Effects of Preexposure Prophylaxis With Coformulated Tenofovir Disoproxil Fumarate and Emtricitabine.

Glidden DV, Mulligan K, McMahan V, Anderson PL, Guanira J, Chariyalertsak S, Buchbinder SP, Bekker LG, Schechter M, Grinsztejn B, Grant RM.

Clin Infect Dis. 2018 Jul 18;67(3):411-419. doi: 10.1093/cid/ciy083.

PMID:
29415175
16.

Ethnicity and HIV vulnerabilities among men who have sex with men in China.

Pan SW, Carpiano RM, Li D, Zhang Z, Schechter MT, Spittal PM, Ruan Y.

AIDS Care. 2018 Aug;30(8):1025-1030. doi: 10.1080/09540121.2018.1428727. Epub 2018 Jan 30.

PMID:
29382213
17.

Does distance to a cystic fibrosis center impact health outcomes?

Johnson B, Ngueyep R, Schechter MS, Serban N, Swann J.

Pediatr Pulmonol. 2018 Mar;53(3):284-292. doi: 10.1002/ppul.23940. Epub 2018 Jan 23.

PMID:
29359447
18.

Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial.

Molina JM, Grund B, Gordin F, Williams I, Schechter M, Losso M, Law M, Ekong E, Mwelase N, Skoutelis A, Wiselka MJ, Vandekerckhove L, Benfield T, Munroe D, Lundgren JD, Neaton JD; INSIGHT START study group.

Lancet HIV. 2018 Apr;5(4):e172-e180. doi: 10.1016/S2352-3018(18)30003-1. Epub 2018 Jan 16.

PMID:
29352723
19.

Achieving Viral Suppression in 90% of People Living With Human Immunodeficiency Virus on Antiretroviral Therapy in Low- and Middle-Income Countries: Progress, Challenges, and Opportunities.

Nachega JB, Sam-Agudu NA, Mofenson LM, Schechter M, Mellors JW.

Clin Infect Dis. 2018 May 2;66(10):1487-1491. doi: 10.1093/cid/ciy008.

PMID:
29324994
20.

Systemic Inflammation, Coagulation, and Clinical Risk in the START Trial.

Baker JV, Sharma S, Grund B, Rupert A, Metcalf JA, Schechter M, Munderi P, Aho I, Emery S, Babiker A, Phillips A, Lundgren JD, Neaton JD, Lane HC; INSIGHT START (Strategic Timing of AntiRetroviral Treatment) Study Group.

Open Forum Infect Dis. 2017 Nov 28;4(4):ofx262. doi: 10.1093/ofid/ofx262. eCollection 2017 Fall.

21.

The incidence of malignancy in clinically benign cystic lesions of the lateral neck: our experience and proposed diagnostic algorithm.

Yehuda M, Schechter ME, Abu-Ghanem N, Golan G, Horowitz G, Fliss DM, Abu-Ghanem S.

Eur Arch Otorhinolaryngol. 2018 Mar;275(3):767-773. doi: 10.1007/s00405-017-4855-6. Epub 2017 Dec 27.

PMID:
29282522
22.

Validation of the Hebrew Version of the Eating Assessment Tool-10 (H-EAT-10).

Abu-Ghanem S, Schechter M, Flesh-Eyni H, Litwin L, Makai E, Oestreicher-Kedem Y, Yehuda M.

Folia Phoniatr Logop. 2016;68(6):261-267. doi: 10.1159/000484557. Epub 2017 Dec 12.

PMID:
29232666
23.

Risk Factors for Gaps in Care during Transfer from Pediatric to Adult Cystic Fibrosis Programs in the United States.

Sawicki GS, Ostrenga J, Petren K, Fink AK, D'Agostino E, Strassle C, Schechter MS, Rosenfeld M.

Ann Am Thorac Soc. 2018 Feb;15(2):234-240. doi: 10.1513/AnnalsATS.201705-357OC.

PMID:
29220199
24.

Treatment Setting and Outcomes of Cystic Fibrosis Pulmonary Exacerbations.

Schechter MS, VanDevanter DR, Pasta DJ, Short SA, Morgan WJ, Konstan MW; Scientific Advisory Group and the Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.

Ann Am Thorac Soc. 2018 Feb;15(2):225-233. doi: 10.1513/AnnalsATS.201702-111OC.

PMID:
29140726
25.

Isoniazid Monoresistance and Rate of Culture Conversion among Patients in the State of Georgia with Confirmed Tuberculosis, 2009-2014.

Salindri AD, Sales RF, DiMiceli L, Schechter MC, Kempker RR, Magee MJ.

Ann Am Thorac Soc. 2018 Mar;15(3):331-340. doi: 10.1513/AnnalsATS.201702-147OC.

PMID:
29131662
26.

Variation in surgical management of neurogenic bowel among centers participating in National Spina Bifida Patient Registry.

Routh JC, Joseph DB, Liu T, Schechter MS, Thibadeau JK, Chad Wallis M, Ward EA, Wiener JS.

J Pediatr Rehabil Med. 2017 Dec 11;10(3-4):303-312. doi: 10.3233/PRM-170460.

PMID:
29125521
27.

Variation in bowel and bladder continence across US spina bifida programs: A descriptive study.

Freeman KA, Castillo H, Castillo J, Liu T, Schechter M, Wiener JS, Thibadeau J, Ward E, Brei T.

J Pediatr Rehabil Med. 2017 Dec 11;10(3-4):231-241. doi: 10.3233/PRM-170450.

PMID:
29125511
28.

Is It Acceptable to Assess Prenatal Smoking Risk to Infants without Considering Socioeconomic Status?

Ong T, Schechter MS.

Am J Respir Crit Care Med. 2018 Apr 1;197(7):965-966. doi: 10.1164/rccm.201708-1750LE. No abstract available.

PMID:
29111767
29.

The Cedar Project: mortality among young Indigenous people who use drugs in British Columbia.

Jongbloed K, Pearce ME, Pooyak S, Zamar D, Thomas V, Demerais L, Christian WM, Henderson E, Sharma R, Blair AH, Yoshida EM, Schechter MT, Spittal PM; Cedar Project Partnership.

CMAJ. 2017 Nov 6;189(44):E1352-E1359. doi: 10.1503/cmaj.160778.

30.

Time to Sputum Culture Conversion and Treatment Outcomes Among Patients with Isoniazid-Resistant Tuberculosis in Atlanta, Georgia.

Schechter MC, Bizune D, Kagei M, Machaidze M, Holland DP, Oladele A, Wang YF, Rebolledo PA, Ray SM, Kempker RR.

Clin Infect Dis. 2017 Nov 13;65(11):1862-1871. doi: 10.1093/cid/cix686.

PMID:
29020173
31.

Inflammatory monocytes expressing tissue factor drive SIV and HIV coagulopathy.

Schechter ME, Andrade BB, He T, Richter GH, Tosh KW, Policicchio BB, Singh A, Raehtz KD, Sheikh V, Ma D, Brocca-Cofano E, Apetrei C, Tracy R, Ribeiro RM, Sher A, Francischetti IMB, Pandrea I, Sereti I.

Sci Transl Med. 2017 Aug 30;9(405). pii: eaam5441. doi: 10.1126/scitranslmed.aam5441.

32.

A decade of improved access to screening is associated with fewer colorectal cancer deaths in African Americans: a single-center retrospective study.

Siba Y, Culpepper-Morgan J, Schechter M, Alatevi E, Jallow S, Onaghise J, Sey A, Ozick L, Sabbagh R.

Ann Gastroenterol. 2017;30(5):518-525. doi: 10.20524/aog.2017.0155. Epub 2017 May 12.

33.

Bladder Reconstruction Rates Differ among Centers Participating in National Spina Bifida Patient Registry.

Routh JC, Joseph DB, Liu T, Schechter MS, Thibadeau JK, Wallis MC, Ward EA, Wiener JS.

J Urol. 2018 Jan;199(1):268-273. doi: 10.1016/j.juro.2017.08.084. Epub 2017 Aug 19.

PMID:
28830753
34.

Neutrophil extracellular trap (NET) levels in human plasma are associated with active TB.

Schechter MC, Buac K, Adekambi T, Cagle S, Celli J, Ray SM, Mehta CC, Rada B, Rengarajan J.

PLoS One. 2017 Aug 4;12(8):e0182587. doi: 10.1371/journal.pone.0182587. eCollection 2017.

35.

Providing Pediatric Palliative Care Education Using Problem-Based Learning.

Moody K, McHugh M, Baker R, Cohen H, Pinto P, Deutsch S, Santizo RO, Schechter M, Fausto J, Joo P.

J Palliat Med. 2018 Jan;21(1):22-27. doi: 10.1089/jpm.2017.0154. Epub 2017 Aug 2.

PMID:
28768111
36.

Comparing effectiveness and outcomes in asthma and cystic fibrosis.

Schechter MS.

Paediatr Respir Rev. 2017 Sep;24:24-28. doi: 10.1016/j.prrv.2017.06.002. Epub 2017 Jun 12. Review.

PMID:
28712576
37.

Immediate Initiation of Antiretroviral Therapy for HIV Infection Accelerates Bone Loss Relative to Deferring Therapy: Findings from the START Bone Mineral Density Substudy, a Randomized Trial.

Hoy JF, Grund B, Roediger M, Schwartz AV, Shepherd J, Avihingsanon A, Badal-Faesen S, de Wit S, Jacoby S, La Rosa A, Pujari S, Schechter M, White D, Engen NW, Ensrud K, Aagaard PD, Carr A; INSIGHT START Bone Mineral Density Substudy Group.

J Bone Miner Res. 2017 Sep;32(9):1945-1955. doi: 10.1002/jbmr.3183. Epub 2017 Jun 26.

PMID:
28650589
38.

Brief Report: Recovery of Bone Mineral Density After Discontinuation of Tenofovir-Based HIV Pre-exposure Prophylaxis.

Glidden DV, Mulligan K, McMahan V, Anderson PL, Guanira J, Chariyalertsak S, Buchbinder SP, Bekker LG, Schechter M, Grinsztejn B, Grant RM.

J Acquir Immune Defic Syndr. 2017 Oct 1;76(2):177-182. doi: 10.1097/QAI.0000000000001475.

PMID:
28639995
39.

Characteristics and response to treatment among Indigenous people receiving injectable diacetylmorphine or hydromorphone in a randomised controlled trial for the treatment of long-term opioid dependence.

Oviedo-Joekes E, Palis H, Guh D, Marchand K, Brissette S, Lock K, MacDonald S, Harrison S, Anis AH, Krausz M, Marsh DC, Schechter MT.

Drug Alcohol Rev. 2018 Jan;37(1):137-146. doi: 10.1111/dar.12573. Epub 2017 Jun 8.

PMID:
28593748
40.

Men's and women's response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorder.

Palis H, Marchand K, Guh D, Brissette S, Lock K, MacDonald S, Harrison S, Anis AH, Krausz M, Marsh DC, Schechter MT, Oviedo-Joekes E.

Subst Abuse Treat Prev Policy. 2017 May 19;12(1):25. doi: 10.1186/s13011-017-0110-9.

41.

Safety profile of injectable hydromorphone and diacetylmorphine for long-term severe opioid use disorder.

Oviedo-Joekes E, Brissette S, MacDonald S, Guh D, Marchand K, Jutha S, Harrison S, Janmohamed A, Zhang DZ, Anis AH, Krausz M, Marsh DC, Schechter MT.

Drug Alcohol Depend. 2017 Jul 1;176:55-62. doi: 10.1016/j.drugalcdep.2017.02.021. Epub 2017 May 10.

PMID:
28521199
42.

The Role of Gender in Suicidal Ideation among Long-term Opioid Users.

Marchand K, Palis H, Fikowski J, Harrison S, Spittal P, Schechter MT, Oviedo-Joekes E.

Can J Psychiatry. 2017 Jul;62(7):465-472. doi: 10.1177/0706743717711173. Epub 2017 May 18.

43.

Risk factors for mortality before age 18 years in cystic fibrosis.

McColley SA, Schechter MS, Morgan WJ, Pasta DJ, Craib ML, Konstan MW.

Pediatr Pulmonol. 2017 Jul;52(7):909-915. doi: 10.1002/ppul.23715. Epub 2017 Apr 24.

PMID:
28436621
44.

International Sexual Partnerships May Be Shaped by Sexual Histories and Socioeconomic Status.

Truong HM, Mehrotra M, Montoya O, Lama JR, Guanira JV, Casapía M, Veloso VG, Buchbinder SP, Mayer KH, Chariyalertsak S, Schechter M, Bekker LG, Kallás EG, Grant RM.

Sex Transm Dis. 2017 May;44(5):306-309. doi: 10.1097/OLQ.0000000000000601.

45.

Ending AIDS as a public health threat by 2030: Scientific Developments from the 2016 INTEREST Conference in Yaoundé, Cameroon.

Hankins CA, Koulla-Shiro S, Kilmarx P, Ferrari G, Schechter M, Kane CT, Venter F, Boucher CA, Ross AL, Zewdie D, Eholié SP, Katabira E.

Antivir Ther. 2017;22(2):179-184. doi: 10.3851/IMP3165. Epub 2017 Apr 7.

46.

Features of Patients With Hereditary Mixed Polyposis Syndrome Caused by Duplication of GREM1 and Implications for Screening and Surveillance.

Lieberman S, Walsh T, Schechter M, Adar T, Goldin E, Beeri R, Sharon N, Baris H, Ben Avi L, Half E, Lerer I, Shirts BH, Pritchard CC, Tomlinson I, King MC, Levy-Lahad E, Peretz T, Goldberg Y.

Gastroenterology. 2017 Jun;152(8):1876-1880.e1. doi: 10.1053/j.gastro.2017.02.014. Epub 2017 Feb 24.

PMID:
28242209
47.

Endovascular and Open Repair of Ruptured Infrarenal Aortic Aneurysms at a Tertiary Care Center.

Schechter MA, Pascarella L, Thomas S, McCann RL, Mureebe L.

Ann Vasc Surg. 2017 May;41:83-88. doi: 10.1016/j.avsg.2016.10.037. Epub 2017 Feb 24.

PMID:
28238928
48.

Reducing practice variation through clinical pathways-Is it enough?

Ren CL, Schechter MS.

Pediatr Pulmonol. 2017 May;52(5):577-579. doi: 10.1002/ppul.23653. Epub 2017 Jan 30. No abstract available.

PMID:
28135046
49.

Socioeconomic Status, Smoke Exposure, and Health Outcomes in Young Children With Cystic Fibrosis.

Ong T, Schechter M, Yang J, Peng L, Emerson J, Gibson RL, Morgan W, Rosenfeld M; EPIC Study Group.

Pediatrics. 2017 Feb;139(2). pii: e20162730. doi: 10.1542/peds.2016-2730. Epub 2017 Jan 16.

50.

Frequency and costs of pulmonary exacerbations in patients with cystic fibrosis in the United States.

Rubin JL, Thayer S, Watkins A, Wagener JS, Hodgkins PS, Schechter MS.

Curr Med Res Opin. 2017 Apr;33(4):667-674. doi: 10.1080/03007995.2016.1277196. Epub 2017 Feb 9.

PMID:
28058864

Supplemental Content

Loading ...
Support Center